Ivyspring international publisher is dedicated to rapid dissemination of important scientific knowledge and discoveries to the global research, academic and professional community. We publish peer-reviewed scientific journals of high quality. All journals are open-access with content immediately available to readers around the world. Our journals are recommended by editors, authors and readers. Our goal is to become the first choice for authors, researchers and scientists to present their finest results, and to disseminate the results in the widest possible way and with high impact.
Ivyspring international publisher is member of Open Access Scholarly Publishers Association (OASPA).
Ivyspring international publisher is a Proprietary, Limited Liability Company located in Sydney, Australia, registered with the Australian government under registration number ACN: 126 316 032. Our company has long history in open-access publishing. Our first open-access journal International Journal of Medical Sciences started publishing in 2004, at which time open-access (OA) concept was still at its initial stage and open-access journals were very few. Our second open-access journal International Journal of Biological Sciences started publishing in 2005. This journal, led by Dr. Chuxia Deng and supported by an outstanding editorial board consisting of leading international scientists, has seen its great success. In 2010 and 2011 respectively, Journal of Cancer and Theranostics started publications. Today, Theranostics, edited by the renowned scientist Dr. Xiaoyuan Chen, has a high impact factor of 8.854. Journal of Cancer (co-edited by Dr. Yan-Gao Man and Prof. Naoto T. Ueno) has an impact factor of 3.609, International Journal of Biological Sciences 3.982, and International Journal of Medical Sciences 2.232. We insist on the quality of our publications, and we do not seek rapid growth of our journals or journal portfolio (unlike some OA publishers) that will compromise the quality of our journals. Articles in our journals are strictly peer-reviewed and every article is also screened for plagiarism using plagiarism detecting software. In Ivyspring, we do not outsource any of our services. We are proud that we create and use our own submission system and manuscript processing system, and do our own in-house manuscript editing, xml generation, PubMed Central/doi submissions, etc., to meet professional standard.
Our journals are funded by author publication fees. Our fees are clearly stated in every journal's website (in the author info pages), and authors are made fully aware of fees (if any) when making any manuscript submission.
Articles in our journals are distributed under the Creative Commons Attribution-NonCommercial 4.0 International License. We also use the CC-BY license for authors funded by Wellcome Trust, RCUK and other funding agencies if required, or if authors request.
Our journals are well received by the scientific communities and gaining reputations as prestigious journals in their fields. It is evident that journals in biomedical fields are undergoing rapid transformation from the traditional subscription models to open access models. Articles published by Ivyspring International Publisher are made available in PubMed Central, the U.S. National Institutes of Health (NIH) digital archive of biomedical journal literature. Authors are also encouraged to self-archive the published articles in their own or institutional websites as well as governmental websites, library websites, without permissions required.
Publication Ethics: our journals follow the guidelines as set out in the Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) on handling potential conflicts of interest of editors, authors, and reviewers. Submissions from editors or members of the editorial board are assigned to other unrelated editors or editorial board members who will ensure unbiased review and decision. Editors-in-chief or handling editors with the assistance of editorial board have complete responsibilities for the peer-review process, decisions, and selection of articles.
There is a zero-tolerance policy towards plagiarism (including self-plagiarism) in our journals. Manuscripts are screened for plagiarism before or during publication, and if found they are rejected at any stage of processing. Other ethical issues, allegations of research misconduct or complaints are handled very seriously and investigations are carried out by the editors and/or editorial office, followed by actions such as reject, withdraw, or retraction of articles.
- XML, SGML, and electronic publishing services;
- journal hosting, advertisement, distribution;
- online submission and peer review system;
- new journal development;
- open access transformation of existing journals;
- co-publishing agreements.
Scientific societies, associations and institutions that wish to establish a co-publishing agreement or transform exiting journals to open access are welcome to contact us here.